TWIPO #56 ~ Interview with Dr. Mark Hatley

On today's podcast, TWIPO host Dr. Timothy Cripe (Nationwide Children’s Hospital) and co-host Dr. Ryan Roberts (Nationwide Children’s Hospital) interview Dr. Mark Hatley (St. Jude Children's Research Hospital). Dr. Hatley discusses how he got into the field of Biological Chemistry in Oncology. Also Dr. Hatley gives an indepth explaination about his research in G-Proteins.

TWiPO #55 ~ Interview with Dr. Chrystal Louis

On this episode of TWiPO podcast Dr. Timothy Cripe (Nationwide Children’s Hospital) and co-host, Dr. Nilay Shah (Nationwide Children’s Hospital) and Dr. Keri A. Streby (Nationwide Children's Hospital) interview Dr. Chrystal Louis (Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine.) Dr. Louis talks to the hosts about her role in both the academic and industry side of oncology. 

TWiPO #54 ~ Interview with Dr. Kim Kramer

On today's TWiPO Podcast host Dr. Timothy Cripe (Nationwide Children’s Hospital) and co-host, Dr. Nilay Shah (Nationwide Children’s Hospital) interview Dr. Kim Kramer (Pediatric Oncologist of Memorial Sloan Kettering.) In this interview they discuss a new cutting edge therapy for treating brain tumors, which involves targeting the tumor intravenously just like any other tumor.

TWiPO #53 ~ Interview with Linda McAllister-Lucas

On today's podcast TWiPO host Dr. Timothy Cripe (Nationwide Children’s Hospital) and co-hosts, Dr. Nilay Shah (Nationwide Children’s Hospital) and Dr. Robyn Dennis (Nationwide Children’s Hospital) Interview Dr. Linda McAllister-Lucas (Chief of Service, Hematology/Oncology of Children's Hospital of Pittsburgh, Associate Professor of Pediatrics, University of Pittsburgh School of Medicine. In their discussion Dr. McAllister-Lucas talks about her research on MALT1 Lymphoma and how this research could advance the field of oncology 

TWIPO #52 ~ Interview with Dr. James Geller

On this TWiPO episode hosts, Dr. Timothy Cripe and Dr. Nilay Shah (Nationwide Children’s Hospital) interview Dr. James Geller (Medical Director at Kidney and Liver Tumors Program, Co-Medical Director at Retinoblastoma Program, Associate Director at Global Cancer Programs, Associate Professor at UC Department of Pediatrics.) Dr. James Geller was one of the original TWiPO members back in 2010. Today Dr. Geller talks about the battle to get access to potential drugs (Ex. Lorvotuzumab [IMGN901]) that can be beneficial to treating pediatric cancers.

TWIPO #36 ~ Interview With Kathleen Neville, MD, on Pediatric Drug Development

January
27, 2014
New York, NY -- This Week in Pediatric Oncology
(TWiPO), the first podcast focusing on pediatric cancer research, announced
that Kathleen Neville,MD, from Children's Mercy Hospital in Kansas City, is a
featured guest on its most recent episode. In this episode, Dr. Kathleen
Neville talks about the challenges of drug development in pediatric cancer with
with host Dr. Tim Cripe (Nationwide Children's Hospital).
Kathleen Neville is the Director of
Experimental Therapeutics in the pediatric cancer program at Children's Mercy
Hospital in Kansas City. She is an Associate Professor of Pediatrics in the
division of pediatric clinical pharmacology, medical toxicology and
hematology-oncology at the University of Missouri-Kansas City School of
Medicine. She is also the chair of the education committee of the American
Society for Clinical Pharmacology and Therapeutics, and a consultant on FDA
pediatric advisory committee, and serves on the FDA Pediatric Oncology
Subcommittee of the Oncologic Drugs Advisory Committee.